Sfoglia per Rivista  

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mostrati risultati da 47 a 66 di 69
Titolo Data di pubblicazione Autore(i) File
Paediatric trial design optimization using prior knowledge in combination with modelling & simulations 1-gen-2017 Borella, Elisa; Oosterholt, S.; Magni, Paolo; Della Pasqua, O.
A PBPK model for the study of Azathioprine pharmacokinetics in rats and prediction in humans 1-gen-2018 Bartolucci, R.; Melillo, N.; Magni, P.
PCA-based modelling in antidepressant trials: a pre-mechanistic approach 1-gen-2012 Marostica, Eleonora; Russu, Alberto; S., Zamuner; R., Gomeni; DE NICOLAO, Giuseppe
Pharmacokinetic Models for Drug and Metabolites Including First Pass Effects: A Priori and A Posteriori Identifiability Analysis 1-gen-2019 Lavezzi, S. M.; Zhang, J.; Magni, P.; De Nicolao, G.; Iavarone, L.
A PK/PD model for tumor-in-host growth kinetics following administration of an antiangiogenic agent given alone or in combination regimens 1-gen-2017 Tosca, ELENA MARIA; Rocchetti, M.; Magni, Paolo
PK/PD modeling of tumor growth inhibition after etoposide administration in vitro and to tumor-bearing rats 1-gen-2015 Pigatto, M. C.; Roman, R. M.; Carrara, Letizia; Magni, Paolo; Dalla Costa, T.
PKPD modelling of MEN1611 anti-tumor effect in xenograft models to predict efficacy threshold concentrations in HER2-positive advanced or metastatic breast cancer patient population 1-gen-2021 Tosca, E. M.; Borella, E.; Piana, C.; Fornari, C.; Bartolucci, R.; Mazzei, P.; Capriati, A.; Merlino, G.; Capano, S.; Laurent, D.; Pellacani, A.; Magni, P.
PopPK-PD modelling of Carboplatin-induced myelosuppression to support therapeutic drug monitoring and dose individualization in cancer patients using Electronic Health Record Data 1-gen-2024 De Carlo, A.; Crul, M.; Schutte, T.; van Zuylen, L.; Bahce, I.; van Valkengoed, C. F. Loo and D.; Huls, H.; Tosca, E. M.; Magni, P.; Bartelink, I.
Population Pharmacokinetic Model of Ibrutinib, a BTK Inhibitor for the Treatment of B-cell malignancies 1-gen-2013 Marostica, Eleonora; Juthamas, Sukbuntherng; David, Loury; Jan de, Jong; Xavier Woot de, Trixhe; An, Vermeulen; DE NICOLAO, Giuseppe; Danelle, James; Italo, Poggesi
Population state-space modelling of patient responses in antidepressant studies 1-gen-2011 Marostica, Eleonora; Russu, Alberto; DE NICOLAO, Giuseppe; R., Gomeni
Predicting tumor volume doubling time and progression-free survival curves in cancer patients from patient-derived-xenograft (PDX) models: a translational model-based population approach 1-gen-2023 Tosca, E. M.; Ronchi, D.; Cossali, M.; Zavetteri, M.; Rocchetti, M.; Magni, P.
Predictive assessments of pharmacokinetic alterations in subjects with renal disease 1-gen-2015 Borella, Elisa; Poggesi, Italo; Magni, Paolo
Prospective Evaluation of a Model-Based approach to select Phase 1 Dosing Regimen for MEN1309/OBT076, a novel antibody drug conjugate (ADC) targeting Ly75 antigen for the treatment of CD205-positive metastatic solid tumours and Non-Hodgkin lymphoma 1-gen-2019 Borella, E.; Mazzei, P.; Piana, C.; Tagliavini, A.; Magni, P.; Buontempo, S.; Tagliacozzi, D.; Fedi, V.; Capriati, A.; Pellacani, A.
Reduced food-intake and sarcopenia in animal models of cancer anorexia-cachexia syndrome: a Dynamic Energy Budget (DEB)-based modeling approach 1-gen-2021 Tosca, E. M.; Montanaro, A.; Rocchetti, M.; Magni, P.
Second order Markov modelling of HAMD responses in depression trials 1-gen-2012 Marostica, Eleonora; Russu, Alberto; S., Zamuner; R., Gomeni; DE NICOLAO, Giuseppe
Second-order indirect response modelling of complex biomarker dynamics 1-gen-2013 A., Russu; Marostica, Eleonora; DE NICOLAO, Giuseppe; I., Poggesi
Steady-state equivalence of drug- and biomarker driven models in tumor growth experiments 1-gen-2014 Sardu, MARIA LUISA; Poggesi, Italo; DE NICOLAO, Giuseppe
Translational model-based approach to assist the dose-range selection of an antibody-drug conjugate entering Phase I 1-gen-2017 Mazzei, P.; Smania, Giovanni; Piana, C.; Magni, Paolo; Binaschi, M.; Bigioni, M.; Merlino, G.; Bugianesi, R.; Chirulli, V.; Simonelli, C.; Capriati, A.; Pellacani, A.
Translational modeling of tumor response to treatment: bridging preclinical to clinical studies 1-gen-2024 Ronchi, D.; Tosca, E. M.; Comets, E.; Bertrand, J.; Magni, P.
A tumor-in-host Dynamic Energy Budget (DEB)-based paradigm for preclinical to clinical translation: predictions of tumor-in-host growth dynamics 1-gen-2021 Tosca, E. M.; Castellano, S.; Ronchi, D.; Rocchetti, M.; Magni, P.
Mostrati risultati da 47 a 66 di 69
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile